Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia

Journal of Antimicrobial Chemotherapy

Volumn 31, Issue 6, 1993, Pages 973-984

  Philpott howard, J N ^a   Wade, J J ^a   Mufti, G J ^a   Brammer, K W ^b   Ehniniger, G ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c Abt l   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; NYSTATIN; POLYENE ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILIARY TRACT DISEASE; CANDIDA KRUSEI; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MYCOSIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; THRUSH;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; CHILD; COMPARATIVE STUDY; FEMALE; FLUCONAZOLE; HUMAN; MALE; MIDDLE AGE; MYCOSES; NEUTROPENIA; NYSTATIN;

EID: 0027248742     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/31.6.973     Document Type: Article

References (25)

1. Berg, D., Plempel, M., Buchel, K.-H., Holmwood, G. & Stroech, K. (1988). Sterol biosynthesis inhibitors. Secondary effects and enhanced in vivo efficacy. Annals of the New York Academy of Sciences 544, 338-47.
2. Buchanan, A. G., Riben, P. D., Rayner, E. N., Parker, S. E., Ronald, A. R. & Louie, T. J. (1985). Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome. Clinical and Investigative Medicine 8, 139-47.
3. Clasener, H. A., Vollaard, E. J. & van Saene, H. K. (1987). Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation. Reviews of Infectious Diseases 9, 295-328.
4. Denning, D. W. & Stevens, D. A. (1989). New drugs for systemic fungal infections. British Medical Journal 299, 407-8.
5. Dreizen, S., McCredie, K. B., Keating, M. J. & Bodey, G. P. (1982). Oral infections associated with chemotherapy in adults with acute leukemia. Postgraduate Medicine 71, 133-46.
6. Epstein, J. B., Truelove, E. L. & Izutzu, K. T. (1984). Oral candidiasis: pathogenesis and host defense. Reviews of Infectious Diseases 6, 96-106.
7. Ezdinli, E. Z., O’Sullivan, D. D., Wasser, L. P., Kim, U. & Stutzman, L. (1979). Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study. Journal of the American Medical Association 242, 258-60.
8. Galgiani, J. N. (1990). Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies. Reviews of Infectious Diseases 12, Suppl. 3, S272-5.
9. Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H. et al. (1992). A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine 326, 845-51.
10. Klastersky, J. (1985). Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis. Clinical Therapeutics 8, 90-9.
11. Louie, T. J., Chubb, H., Bow, E. J., Conly, J. M., Harding, G. K. M., Rayner, E. et al. (1985). Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutrop>enic patient. Reviews of Infectious Diseases 7, Suppl. 4, S747-61.
12. Meunier-Carpentier, F. (1984). Chemoprophylaxis of fungal infections. American Journal of Medicine 76, 652-6.
13. Patterson, T. F., George, D., Miniter, P. & Andriole, V. T. (1991). The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. Journal of Infectious Diseases 164, 575-80.
14. Persons, D. A., Laughlin, M., Tanner, D., Perfect, J., Gockerman, J. P. & Hathom, J. W. (1991). Fluconazole and Candida krusei fungemia. New England Journal of Medicine 325, 1315.
15. Rozenberg-Arska, M., Dekker, A. W., Branger, J. & Verhoef, J. (1991). A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia. Journal of Antimicrobial Chemotherapy 27, 369-76.
16. Saag, M. S. & Dismukes, W. E. (1988). Azole antifungal agents: emphasis on new triazoles. Antimicrobial Agents and Chemotherapy 32, 1-8.
17. Samonis, G., Rolston, K., Karl, C., Miller, P. & Bodey, G. P. (1990). Prophylaxis of oropharyngeal candidiasis with fluconazole. Reviews of Infectious Diseases 12, Suppl. 3, S369-S373.
18. Schmeiser, T., Kurrle, E., Arnold, R., Krieger, D., Heit, W. & Heimpel, H. (1988). Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation. Infection 16, 19-24.
19. Shepp, D. H., Klosterman, A., Siegel, M. S. & Meyers, J. D. (1985). Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment. Journal of Infectious Diseases 152, 1257-63.
20. Stone, H. H., Kolb, L. D., Currie, C. A., Geheber, C. E. & Cuzzell, J. Z. (1974). Candida seprais: pathogenesis and principles of treatment. Annals of Surgery 179, 697-711.
21. Troke, P. F., Andrews, R. J., Pye, G. W. & Richardson, K. (1990). Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Reviews of Infectious Diseases 12, Suppl. 3, S276-80.
22. Walsh, T. J., Aoki, S., Mechinaud, F., Bacher, J., Lee, J., Rubin, M. et al. (1990). Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. Journal of Infectious Diseases 161, 755-60.
23. Wamock, D. W., Burke, J., Cope, N. J., Johnson, E. M., von Fraunhofer, N. A. & Williams, E. W. (1988). Fluconazole resistance in Candida glabrata. Lancet 2, 1310.
24. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. & Saral, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine325, 1274-7.
25. Young, L. S. (1982). The outlook for antifungal prophylaxis in the compromised host. Journal of Antimicrobial Chemotherapy 9, 338-40.